PROFECTUS BIOSCIENCES, INC of BALTIMORE, MD, a company, filed a Form D amendment with the SEC on 2010-04-06. The offering totals $6.0M, of which $6.0M was reported sold. Industry: Biotechnology.
Showing 25 of 38 people.
| Name | Role | Location |
|---|---|---|
| Brian Adamsky | Director | Radnor, PA |
| Joseph Berardino | Director | Baltimore, MD |
| Stewart G Greenebaum | Director | Baltimore, MD |
| William A Haseltine | Director | Baltimore, MD |
| Thomas G Lynch | Director | Baltimore, MD |
| Jeffrey Meshulam | Executive Officer | Baltimore, MD |
| Thomas Lynch | Director | San Diego, CA |
| Donald Caldwell | Director | Boothwyn, PA |
| Shawn Patrick O'Brien | Director | King of Prussia, PA |
| Shawn Patrick O'Brien | Executive Officer | King of Prussia, PA |
| William K Haseltine | Director | Baltimore, MD |
| Michael K Greenebaum | Director | Baltimore, MD |
| Thomas G Pease | Director | Baltimore, MD |
| Thomas G Pease | Executive Officer | Baltimore, MD |
| Frederick C Tecce | Director | Baltimore, MD |
| Brian K Adamsky | Director | Baltimore, MD |
| Terry A Lierman | Director | Baltimore, MD |
| Jeffrey N Meshulam | Director | Baltimore, MD |
| Jeffrey N Meshulam | Executive Officer | Baltimore, MD |
| M.G. A Sarngadharan | Director | Baltimore, MD |
| Thomas G Paese | Director | Baltimore, MD |
| Thomas G Paese | Executive Officer | Baltimore, MD |
| Tom K Pease | Executive Officer | Baltimore, MD |
| Alexander G Rich | Director | Baltimore, MD |
| Alexander G Rich | Executive Officer | Baltimore, MD |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2016-12-12 | D/A | $4.0M | $300K |
| 2016-05-13 | D | $500K | $300K |
| 2014-08-04 | D/A | $7.5M | $7.5M |
| 2014-04-17 | D/A | $7.5M | $7.3M |
| 2013-08-13 | D/A | $7.0M | $7.0M |
| 2013-02-11 | D/A | $7.0M | $7.0M |
| 2011-07-18 | D/A | $6.8M | $6.8M |
| 2009-07-28 | D | $5.0M | $5.0M |